Kevin Burnand Prize

2017 – Royal College of Surgeons in Ireland

THERAPEUTIC APPROACHES TO THE METABOLIC RELATIONSHIP BETWEEN PANCREATIC DUCTAL ADENOCARCINOMA AND PANCREATIC STELLATE CELLS THROUGH TARGETING OF LACTATE DEHYDROGENASE

J Moir(1,2), J Mann (1), D Mann (1), D Manas (2), R Charnley (2), J French (2), S White (2)
(1) Fibrosis Lab, Institute of Cellular Medicine, Newcastle University (2) HPB Unit, Freeman Hospital, Newcastle Upon Tyne


2016 – Royal College of Surgeons of England

HLA-SPECIFIC ALLOANTIBODY DEVELOPMENT CAN BE PREDICTED USING A NOVEL COMPUTATIONAL SCORING SYSTEM THAT QUANTIFIES 3-DIMENSIONAL ELECTROSTATIC POTENTIAL DIFFERENCES BETWEEN DONOR AND RECIPIENT HLA MOLECULES

DH Mallon (1), C Kling (2), JA Bradley (1), CJ Taylor (3), D Kabelitz (2), V Kosmoliaptsis (1)
(1) Department of Surgery, University of Cambridge (2) Institute of Immunology, University of Kiel (3) Tissue Typing Department, Addenbrooke’s Hospital, Cambridge


2015 – Durham University

PRO-ANGIOGENIC CD16+VE MONOCYTES SALVAGE THE CRITICALLY ISCHAEMIC LIMB

AS Patel, P Saha, A Kerr, F Ludwinski, A Bajwa, A Smith, B Modarai. Academic Department of Surgery, Cardiovascular Division, King’s College London.


2014 – Robinson College, University of Cambridge

THE TISSUE FACTOR PATHWAY MAY PROMOTE BREAST CANCER STEM CELL ACTIVITY

H Shaker (1,2), H Harrison (1), R Clarke (3), G Landberg (1), N J Bundred (2), CC Kirwan (2). Molecular Pathology Group, Breakthrough Breast Cancer Unit, Paterson Institute for Cancer Research (1), Manchester Academic Health Science Centre, Department of Academic Surgery, University Hospital of South Manchester (2), Breast Biology Group, Paterson Institute for Cancer Research (3), Manchester


2013 – Royal Society of Medicine, London

A novel cytosolic protein complex regulates LOX-1 scavenger receptor-mediated endocytosis of proatherogenic oxidised low-density lipoprotein particles.

N A Mughal (1,2), K Freestone (2), Z Holloway (3), AP Monaco (3), D A Russell (1), S Homer-Vanniasinkam (1,2), S Ponnambalam (2), Leeds Vascular Institute, The General Infirmary at Leeds, Leeds, UK (1), Endothelial Cell Biology Unit, Leeds Institute for Genetics, Health & Therapeutics, University of Leeds, UK (2), Wellcome Trust Centre for Human Genetics, University of Oxford, UK (3).


2012 – University of Nottingham

Characterisation of quiescent intestinal stem and cancer stem cells.

S Buczacki (1), R Kemp (1), A Klein (2), RJ Davies (3), D Winton (1), (1) Cancer Research UK, Cambridge Research Institute, Cambridge UK, (2) Harvard Medical School, Boston USA, (3) Cambridge Colorectal Unit, Addenbrooke’s Hospital, UK.

Comments are closed.